HT Genetic Screen Contract Research Services
Cellecta specializes in contract solutions for high-throughput genetic screening for academic and industrial customers. Our research organization focuses primarily on developing and implementing flexible and scalable broad-based screening and analysis approaches that identify the mechanisms regulating biological processes to expedite the discovery and characterization of novel therapeutic targets and drugs. The unique capabilities of Lentiviral and shRNA technologies provide a platform that enable genome-wide functional screening, and to identify and validate genes involved in critical biological and pathological responses:
Our basic services and capabilities are described on the following pages. Of course, it is not possible to describe all variations and we are always interested to hear how we might help you with your research. Generally, we provide full-scale contract discovery research, including genetic screening, data analysis, and validation for gene and target discovery. If you are interested in an advanced or complex service project, we would be happy to discuss the details, develop a plan, and provide a quote. For more information, please contact us.
If you wish to receive the latest news and product updates by email, please register.
